Dermapharm Reports H1 Profit Growth, Vipshop Misses Q2 Profit Estimates

Dermapharm reported profit growth for the first half of 2026, boosting its shares, while Vipshop missed its Q2 2026 profit estimates, which weighed on its stock. These earnings reports highlight varied performances in the pharmaceutical and e-commerce sectors.